After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that N/A.
Stocks Info
Inozyme Pharma Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Inozyme Pharma Inc is $255.02M. A total of 49.75 million shares were traded on the day, compared to an average of 817.31K shares.
In the most recent transaction, Treco Douglas A sold 8,819 shares of INZY for 0.89 per share on Apr 02 ’25. After the transaction, the CEO & Chairman now owns 41,046 company shares.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, INZY has a high of $6.24 and a low of $0.72.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. INZY’s latest balance sheet shows that the firm has $111.80M in Cash & Short Term Investments as of fiscal 2021. There were $3.37M in debt and $11.63M in liabilities at the time. Its Book Value Per Share was $0.49, while its Total Shareholder’s Equity was $109.27M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for INZY is Buy with a score of 4.44.
